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Summary: The reliability of bilirubin analyses is especially important in cases of neonatal hyperbilirubinaemia.
However, when the means of the results of external quality control surveys and the method-dependent stated
values for control sera were compared with reference method values, differences of up to 10% were found.
Further inaccuracy arose from interlaboratory imprecision, which showed coefficients of variation of at least
7%, and from greater or lesser interference from contamination of samples with haemoglobin.
The present work investigates whether the current situation can be improved by available means.
Introduction errors are responsible for interlaboratory varia-
_ . . - . . ,. - r tions in the results, even when these laboratoriesOne prerequisite for an unambiguous diagnosis of , ^ Λ
, ι ι Μ- ι · . . " j use the same methods,
neonatal hyperbihrubmaemia is an accurate deter-
mination of the total bilirubin concentration in serum. The diagrams for exchange transfusions (5 — 7) and
Errors can lead to therapeutically unsound decisions, phototherapy (8, 9), which are used as aids in estab-
which in turn may result in a more or less pronounced lishing a therapeutic scheme, do not take account of
brain defect (1). Thus, exacting demands are made on method-dependent bilirubin values. A critical situa-
the reliability of the clinical^chemical analysis, and so tion therefore arises, in which the unsatisfactory corn-
far these demands have only been partially met (2—4): parability of the results from different laboratories
~ . - - .- ~ working with varying methods and equipment can
— Current routine methods are not specific. Sources
 1 .
 β
 , . . ,
 Λ - - ,* mf. r . γ · t_ ι · * lead repeatedly to controversial decisions (10).of interference are inherent in the analysis mate-
rial, especially that of haemoglobin and its deriv- "Total bilirubin" consists of up to 5 fractions in the
atives, which affect the principles of analysis in serum, whose relative quantities are so far undefined:
different ways and lead to method^related varia^
 4 N . . - 1U . , , u.r u.
. " . . " 1) unconjugated, albumin-bound bihrubm,
tions in the results. ^
 u.v ,. , .,2) bilirubin-monoglucuromde,
— Bilirubin is comparitively unstable. Primary bili- 3) bilirubin-diglucuronide,
rubin standards that are easy to use for regular 4) unconjugated bilirubin which is covalent bound to
calibration and applicable for all routine methods albumin ("δ-bilirubin") (11) and
are therefore not available. In addition, systematic 5) free, unconjugated bilirubin.
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The development of a reference method in its strictest
sense (12) is hardly possible for such a group deter-
mination.
Downas et al. (13) have, however, described a method
for the determination of total bilirubin ("candidate
reference method") which extensively satisfies the re-
quirements of a reference method. This will, in the
following, simply be called the reference method, de-
spite the reservations inherent here. Furthermore,
since 1986, a stable, secondary bilirubin standard de-
veloped by Vink (14) has been available, which con-
tains bovine albumin, and is suitable only for chem-
ical, not for direct photometric, biliruBin determina-
tion.
Under the given conditions, an attempt was made to
test with optimal reliability the bilirubin concentration
of 3 control specimens used for external quality con-
trol surveys as well as of several commercially avail-
able control samples, and to compare these results
with those obtained by routine methods. The results
from external quality control surveys for neonatal
bilirubin carried out in cooperation with the Deutsche
Gesellschaft f r Klinische Chemie served as a criterion
for the performance of routine methods.
Materials and Methods
Sample mater ia l
Standards
Bilirubin standards 2 and 3 were from the Rijksinstitut voor
Volksgesondheit en Milieuhygiene in Bilthoven. the Nether-
lands.
Standard 2: Lot no. 850723, assigned value 98.8 μπιοΐ/ΐ.
Standard 3: Lot no. 850726, assigned value 290 μπιοΐ/ΐ (15).
Quality control survey samples
Unconjugated bilirubin was dissolved in a solution of albumin,
human serum or bovine serum. Identical volumes of each ma-
terial were placed in small test tubes and lyophylized. The
material had partly been produced in our own laboratory and
partly provided as a finished product by commercial companies.
The composition of the material is specified for 6 quality control
surveys, the results of which will be described in detail:
- Samples A and Β of quality control surveys 3/83-3/84 each
contained the same mixture of albumin and bilirubin; spec-
imen Β of quality control survey 3/83 was, however, addi-
tionally spiked with 310 μηποΐ/ΐ haemoglobin, and specimen
Β of quality control surveys 1/84—3/84 with 93 μιηοΐ/ΐ
haemoglobin.
- Specimens 101, 102 and 103, analysed in the quality control
surveys 1/87, 2/87 and 3/87, consisted of human serum and
varied concentrations of bilirubin.
Other control samples
The commercially available control samples were provided by
the following companies:
Sta-Bil (human albumin, No BIC-975) Travenol, M nchen.
Kontrollogen-Bilirubin (human serum, No 613415) Behring-
werke, Marburg.
Precibil (human serum No 1-211) Boehringer-Mannheim,
Mannheim.
Controbil (bovine serum No 705) Merck, Darmstadt.
Reference method values
Time of the determinations: February to April 1987.
The reference method values of specimens 101, 102 and 103
had been determined previously under similar, though some-
what less elaborate, conditions. The results of this first deter-
mination were slightly higher than the second; only the second
determination is used here.
Participating laboratories
Six laboratories took part in the present inquiry into reference
method values. These were headed by W. Appel, Karlsruhe; B.
G. Blijenberg, Rotterdam; H. Bret t Schneider, Penzberg; G. Br g-
mann, T bingen; H. Schlebusch, Bonn and H. Wisser, Stuttgart.
Determination method
All quantitative determinations to establish reference method
values were carried out according to Doumas et al. (13).
Photometer controls
The spectrophotometers used were first tested: the wavelengths
with a holmium nitrate solution and the absorption with gray
filters, whose absorption for wave-length 598 nm were measured
by the Physikalisch-Technische Bundesanstalt, Berlin.
Volume controls
Each laboratory controlled its volume measurements according
to the recommendations issued by the National Committee for
Clinical Laboratory Standards, USA (NCCLS, Vol. 4 No 6).
Experimental desigti
Each laboratory determined the bilirubin concentration in 2
standard samples, 3 quality control survey samples and 4 com-
mercial control samples. All determinations were performed in
duplicate, in 5 series of analyses.
Establishing the reference method values
After eliminating the results from one reference laboratory,
which showed the largest scatter, the median of the remaining
90 values for one given specimen was fixed as the reference
method value.
External qua l i ty control surveys
Quality control surveys for the determination of neonatal bili-
rubin have taken place three times yearly since 1983. The
laboratories that applied for survey participation are each, with
few exceptions, part of a hospital with facilities for the newborn.
For each survey the participants analysed* two samples, A and
B. In the first survey of 1983, sixty pairs of analytical results
were sent for quality control evaluation; in the third survey of
1987, this number had increased to 160.
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Evaluation
After every quality control survey, the results were divided into
several subgroups according to the method of analysis. For
every subgroup, statistical parameters· were calculated: mean
value, standard deviation and coefficient of variation.
Methods taken into account
Jcndrassik-Grof method (16); 2.5-dichlorophenyldiazonium
(DPD)-method (17); direct spectrophotometry without dilution
(bilirubinometer). Beginning with quality control survey 2/86,
the results of direct speclrometry with dilution (18) were also
evaluated separately.
Transformation of analysis results with the help of a ctive
standard
The participants' individual results for sample A of the quality
control surveys 1/87 and 3/87 (A;) were multiplied with the
quotient from the reference method value for sample B (RMVB)
and the individual result for Sample B (B·,).
Αι · RMVB
= Αίβ
From the values standardized in this way (Ais), the statistical
parameters — mean value and standard deviation — were
calculated (fig. 1).
Criterion for excluding mean values and standard deviations in
figure 1
When a first calculation of mean value and standard deviation
gave a single value differing from the mean by plus or minus
3 standard deviations, this was eliminated before a second and
final calculation.
Results and Discussion
Intel-laboratory precision
An important purpose of the quality control surveys
is to determine the degree to which the results from
different laboratories differ from one another. An
often very rough but otherwise very graphic estimate
of the extent of scatter in quality control results
emerges from the standard deviation or the relative
standard deviation. It proved repeatedly to be the
case that interlaboratory precision increased more or
less significantly after the start of the quality control
programme. This was not the case, however, when
neonatal bilirubin was determined, or, at best, im-
provement was only apparent in its initial stage.
In table 1 the mean values of the coefficients of
variation are given for each of the 6 control samples
that were analysed within a given year.
According to these, during the last 5 years there was
no convincing improvement in interlaboratory preci-
sion for the 3 analysis methods most often used by
the participants. A slight improvement was noticeable
only over the last 2 years when all the results were
taken into account without differentiating the meth-
ods. The available data allow the conclusion that this
was due to a reduction in the differences between the
mean values of each method collective.
This practically unaltered interlaboratory precision
found in participants with the same analysis princi-
ples, points to the fact that needed improvement can
hardly be expected by increased care on the part of
the analysts. Apparently other measures are needed
to improve a precision impaired most likely, and to
the greatest extent, by systematic errors of differing
magnitude.
Accuracy
Table 2 shows that wide differences can exist between
the results obtained by reference methods and those
by routine methods. Not only the mean values of the
results from quality control surveys but also the stated
values cited by the suppliers of the control sera de-
viated up to 10% from those of reference methods.
These findings accord with the results of previous
studies (e.g. I.e. (3)). Such a noticeable difference
raises the question of whether the calibration of the
usual routine methods might not need to be re-ex-
amined and corrected.
Tab. 1. Means of some method-dependent data from three external quality control surveys for bilirubin determinations per year,
each including the analyses of two specimens: mean of the number of participants (n), mean of the coefficients of variation
(CV), mean of the relative differences (D%) between the methods means and the total means of all values for a given
specimen.
Year
1983
1984
1985
1986
1987
Jendrassik-Grof
n
30
40
39
43
43
CV(%)
7.3
9.3
5.9
7.2
6.2
D(%)
5.2
3.0
3.8
1.7
3.0
2,5-Dichlorophenyl
diazonium reagent
n
14
24
34
45
53
CV (%)
10.9
7.2
6.6
6.9
6.8
D (%)
3.0
4.7
2.5
2.3
1.5
Direct photometry
without dilution
n
17
25
29
43
42
CV (%)
7.9
9.1
10.0
7.5
7.7
D (%)
8.2
7.7
8.3
3.5
3.3
All methods
CV (%)
9.2
10:0
9.5
7.9
7.3
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Tab. 2. Results of the determinations of "reference method values" (16% and 84% percentiles in parenthesis) for 9 bilirubin
specimens (2 standards, 3 specimens, 101 — 103, used in external quality control surveys and 4 commercial control
specimens) and the means of survey results1) and the stated values2) of specimen producers, respectively.
Specimen
Standard 2 (98.8 μιηοΐ/ΐ)
Standard 3 (290 μπχοΐ/ΐ)
101
102
103
Sta-Bil
Kontrollogen-Bilirubin
Precibit
Controbil
Reference method value
(μηιοΐ/l)
97.9 (96.0- 99.1)
286 (280 -289)
91.8 (88.5- 93.9)
178 (174 -180)
266 (262 -268)
316 (311 -321)
333 (327 -337)
273 (268 -276)
303 (297 -309)
Method dependent
Jendrassik-Grof
(μηιοΐ/ΐ)
96.11)
1881)
2811)
3252)
3441)
3002)
3222)
values
2,5-Dichlorophenyl-
diazonium method
(μπιοΐ/ΐ)
ΙΟΙ1)
1951)
2881)
3561)
3002)
31 12)
Direct photometry
without dilution
(μΐηοΐ/ΐ)
1041)
201 ')
292')
3101)
Possible effects from the use of standards
Independent of the possible necessity for new calibra-
tion procedure^ for routine methods, and considering
the great diagnostic importance of neonatal bilirubin
determination, the calibration of every analytical se-
ries should prove more reliable with the help of a
supplementary, if only, secondary standard. The ma-
terial developed in the Netherlands (14) is available
as a standard for chemical methods.
To what extent this could improve the reliability of
results is shown in an evaluation made by the control
survey 1/87 (fig. 1), in which samples 102 and 103,
from the same production supply, were studied. The
first group of columns shows the mean values and
standard deviations arrived at for the first of the two
samples (A). These results would have been much
better if the participants had used the second sample
(B,) as a standard for the first, which was exactly the
requirement we made for our later calculation. The
resulting second group of columns shows a very good
match up between the means and the reference
method values. Likewise, a considerable improvement
in interlaboratory precision would have occurred for
all methods of analysis. Both accuracy and interlab-
oratory precision would, in practice, be feasible if
systematic intralaboratory errors of varying degree
were eliminated by the use of suitable standards.
330
*3* 320
| 310
^ 300
~ 290
| 280
~ 270
I 260
δ 250
0
η
Survey 1/87
Specimen A
50 60 48 19
SD[/jmol/l] 18 18 22 18 8.0 5.5 14 8.2
"Standard" without with
Survey 3/87
Specimen A
50 41 21
15 18 18 17
without
10 12 13 U
with
Fig. 1. Means and standard deviations (SD) of bilirubin determinations in specimen A of the surveys 1/87 and 3/87 and
transiormed j-neans and standard deviations for the same specimen calculated on the basis of the individual results for
s fictive standards with 178 μπιοΐ/ΐ and 333 μηιοί bilirubin respectively.
S 2,5-Dichlorophenyldiazonium method
B Direct spectrophotometry without dilution
H Direct spectrophotometry with dilution
T Standard deviation
n = number of results
>- reference method value
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Again, specimen 103 of the control samples from the
quality control survey 3/87 served as sample A,
whereas the Kontrollogen-Bilirubin (No. 613415)
was sample B (B3). The specimens were from different
suppliers and therefore had dissimiliar matrices. The
third column group in figure 1 shows, with no major
difference from the first, the statistical parameters of
the original results for sample A. The fourth group
shows these same parameters after transformation
with the individual results and with the reference
method values for sample B3.
Again, with all methods there was a marked, if some-
what slighter, improvement in interlaboratory preci-
sion because of the transformation. The conversion
using the diazo-methods even matched the reference
method value almost exactly. But in the case of direct
photometry, with and without dilution, the opposite
effect occurred, i. e. accuracy decreased. This phenom-
enon can be partly explained if it is assumed that the
human serum matrix of sample A contained caroten-
oids which could have influenced the photometric
determinations more than the chemical ones. On the
other hand, it is not clear why the mean of the
photometric determinations of sample B3 (Kontrol-
logen-Bilirubin) was significantly lower than the ref-
erence method value (tab. 2). Control samples for
which reference method values are available are there-
fore not automatically suitable as calibrators for bil-
irubin determination.
In connection with this observation it is worth noting
that the specificity of direct photometry is called into
question by the varying absorption spectra of the
individual bilirubin fractions (11). This is surely one
source of the criticism that has been levelled at direct
photometry, especially when applied without dilution
of the samples (3, 4, 19).
Haemoglobin interference
In four of the quality control surveys from 1983 and
1984, two specimens each were studied that were
identical in matrix and bilirubin concentration. One
of the two samples, however, was mixed with hae-
moglobin to simulate a medium or light haemolysis.
These experiments took account of the experience that
in determining neonatal bilirubin in patients' samples,
an analysis often must be made with serum or plasma
that is more or less haemolytic.
With one exception all analysis methods gave a me-
dian for the sample with haemoglobin that was lower
than for those without (fig. 2). In the case of routine
methods using the diazo-technique, this difference
must be noted as an effect due to lack of specificity
of known origin. Direct photometry without dilution,
however, which is supposed to eliminate the interfer-
ence from haemoglobin by measurements with 2 dif-
ferent wavelengths, does not seem to satisfactorily
fulfil this requirement.
Amount of
haemoglobin
added [/jmol/l] 310 93 93 93
1.0
cσ
i 'S 0.9
ω
Bilirubin[)umol/'l] 310
(approximately)
Survey 3/83
180
1/84
400
2/84
300
3/84
Fig. 2. Relative levels of the means of the bilirubin determinations of four quality control surveys in which the specimens Β were
spiked with» haemoglobin, compared with the means for the specimens A (1.0) which were identical except for the
haemoglobin contamination.
Π Jendrassik-Grof -method
S 2,5-Dichlorophenyldiazonium method
• Direct spectrophotometry without dilution
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Conclusions
Considering the special importance of bilirubin deter-
mination for neonatology, the state of analysis today
is unsatisfactory. Substantial improvement could
probably be brought about by means that are already
available or could, in all probability, shortly become
available.
1. Accuracy and precision of the results would be
decisively improved if their calculation could be
examined with the additional help of secondary
standards. Samples developed as reference material
in the Netherlands (15) are available for use as
secondary standards for diazo-methods (cf. Ma-
terial and Methods). Despite all reservations about
using control samples as calibrators, commercial
control series might also serve the same purpose.
The prerequisite would be, however, that they are
tested for suitability as calibrators for defined
methods and that the reference method values for
bilirubin concentrations are available.
As a result of being easy to work with, direct
photometry is often used and, by a standardized
method suggested by Blijenberg et al. (20), could
prove to be a pragmatic step towards more reliable
results.
2. Normal unspecific analysis methods could be re-
placed by the specific ones of Donmas et al. if they
could be modified so that smaller sample volumes
can be handled. According to the authors' test
results (13), the problem of haemoglobin interfer-
ence would thus be solved.
Improved analysis could bring about a situation
in which a revision of the decision limits given in
scientific publications (5 — 7) will need to be dis-
cussed.
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